TY  - JOUR
AU  - Zhou, Zien
AU  - Jardine, Meg J
AU  - Li, Qiang
AU  - Neuen, Brendon L
AU  - Cannon, Christopher P
AU  - de Zeeuw, Dick
AU  - Edwards, Robert
AU  - Levin, Adeera
AU  - Mahaffey, Kenneth W
AU  - Perkovic, Vlado
AU  - Neal, Bruce
AU  - Lindley, Richard I
AU  - CREDENCE Trial Investigators*
PY  - 2021
DO  - 10.1161/STROKEAHA.120.031623
UR  - https://hdl.handle.net/10668/27809
T2  - Stroke
AB  - Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and...
LA  - en
KW  - atrial fibrillation
KW  - canagliflozin
KW  - glomerular filtration rate
KW  - hemorrhagic stroke
KW  - ischemic stroke
KW  - Atrial Fibrillation
KW  - Canagliflozin
KW  - Diabetes Mellitus, Type 2
KW  - Diabetic Nephropathies
KW  - Humans
KW  - Meta-Analysis as Topic
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Stroke
TI  - Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
TY  - research article
VL  - 52
ER  -